369 related articles for article (PubMed ID: 17037037)
21. Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation.
Chow LM; Nathan PC; Hodgson DC; Jenkin D; Weitzman S; Grant RM; Manson D; Bross A; Doyle JJ; Danjoux C; Greenberg ML
J Clin Oncol; 2006 Dec; 24(36):5735-41. PubMed ID: 17179107
[TBL] [Abstract][Full Text] [Related]
22. [Five-year outcome of a new combination chemotherapy with CEA/ABVD for advanced Hodgkin's disease with poor prognosis].
Kharchenko VP; Datsenko PV; Panyshin GA; Sotnikov VM; Mel'nik IuD
Vopr Onkol; 2006; 52(5):531-7. PubMed ID: 17168361
[TBL] [Abstract][Full Text] [Related]
23. [Comparative evaluation of subtotal irradiation and polychemotherapy in the treatment of patients with lymphogranulomatosis].
Shust VF
Vestn Rentgenol Radiol; 1994; (4):18-21. PubMed ID: 7785193
[TBL] [Abstract][Full Text] [Related]
24. [Clinical features and combined treatment of the central nervous system in Hodgkin's disease].
Filatova LV; Gershanovich ML
Vopr Onkol; 2008; 54(5):643-52. PubMed ID: 19069483
[TBL] [Abstract][Full Text] [Related]
25. Don't throw out the baby with the bathwater: on optimizing cure and reducing toxicity in Hodgkin's lymphoma.
Yahalom J
J Clin Oncol; 2006 Feb; 24(4):544-8. PubMed ID: 16446326
[No Abstract] [Full Text] [Related]
26. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy or combined modality treatment: the optimal treatment for Hodgkin's disease.
Diehl V
J Clin Oncol; 2004 Jan; 22(1):15-8. PubMed ID: 14657229
[No Abstract] [Full Text] [Related]
28. Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.
Engert A; Franklin J; Eich HT; Brillant C; Sehlen S; Cartoni C; Herrmann R; Pfreundschuh M; Sieber M; Tesch H; Franke A; Koch P; de Wit M; Paulus U; Hasenclever D; Loeffler M; Müller RP; Müller-Hermelink HK; Dühmke E; Diehl V
J Clin Oncol; 2007 Aug; 25(23):3495-502. PubMed ID: 17606976
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy and radiotherapy in Hodgkin's lymphoma: joining in or splitting up?
van der Maazen RW; Raemaekers JM
Curr Opin Oncol; 2006 Nov; 18(6):660-6. PubMed ID: 16988591
[TBL] [Abstract][Full Text] [Related]
30. Advances in treatment for Hodgkin's disease.
Wiernik PH
Mt Sinai J Med; 1992 Oct; 59(5):405-7. PubMed ID: 1435836
[No Abstract] [Full Text] [Related]
31. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
[TBL] [Abstract][Full Text] [Related]
32. Salvage therapy in Hodgkin's lymphoma.
Mendler JH; Friedberg JW
Oncologist; 2009 Apr; 14(4):425-32. PubMed ID: 19342476
[TBL] [Abstract][Full Text] [Related]
33. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
[TBL] [Abstract][Full Text] [Related]
34. Pediatric Hodgkin's disease: current concepts in diagnosis and management.
Kaicker S; Kelly K
Indian Pediatr; 2000 Sep; 37(9):933-8. PubMed ID: 10992328
[No Abstract] [Full Text] [Related]
35. Primary localized stages I and II non-Hodgkin's lymphoma of the nasopharynx: a retrospective 17-year single institutional experience.
Mohammadianpanah M; Ahmadloo N; Mozaffari MA; Mosleh-Shirazi MA; Omidvari S; Mosalaei A
Ann Hematol; 2009 May; 88(5):441-7. PubMed ID: 18931844
[TBL] [Abstract][Full Text] [Related]
36. [Relevance of certain factors in the effectiveness of chemoradiotherapy for Hodgkin's disease].
Kanaev SV; Gershanovich ML; Pozharisskiĭ KM; Girshovich MM; Golovanov SG
Vopr Onkol; 2005; 51(1):56-9. PubMed ID: 15909808
[TBL] [Abstract][Full Text] [Related]
37. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
38. New strategies for the treatment of advanced-stage Hodgkin's lymphoma.
Diehl V; Engert A; Re D
Hematol Oncol Clin North Am; 2007 Oct; 21(5):897-914. PubMed ID: 17908627
[TBL] [Abstract][Full Text] [Related]
39. [Some aspects of reproductive function and social adaptation after comprehensive therapy of childhood Hodgkin's disease].
Susuleva NA; Il'iashenko VV
Vopr Onkol; 1997; 43(4):399-402. PubMed ID: 9381688
[TBL] [Abstract][Full Text] [Related]
40. [Results of combined therapy for lymphogranulomatosis in children].
Kolygin BA; Lebedev SV; Borodina AF; Kochurova NV; Malinin AP; Safonova SA; Punanov IuA
Vopr Onkol; 2000; 46(2):232-5. PubMed ID: 10853430
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
